Company
GINPACT was co-founded in Hong Kong in August 2024 by world-class biologists and technology investors. The company is dedicated to modernising, democratising, and globalising precious traditional herbs, such as ginseng and notoginseng, through cutting-edge biotechnology. Its flagship product, Rare GINPACT Essence, stems from over two decades of scientific research into Panax species and fermentation technology. Utilising proprietary and original technology, the company converts cultivated ginseng and notoginseng into rare, natural tonic essence that mirrors the potency of wild mountain ginseng.In collaboration with top universities in Hong Kong, its research has substantiated that GINPACT supports DNA repair, mitochondrial function restoration, and NAD+ level elevation, all while maintaining an exceptional safety profile. By validating the traditional efficacy of wild mountain ginseng—"nourishing the five internal organs and calming the spirit"—with modern science, the company delivers a product that is not only potent but also free from pesticide residues and heavy metals, ensuring the highest standards of food safety.
Description
As a member of MCMIA, the company focuses in the field of natural product exploration and applications.
